Researchers everyone is working on an HIV vaccine

In the 35 years since the beginning of the HIV epidemic, only four vaccines have been tested on humans and the best one has reduced the infection rate by 31%, which has led to stopping clinical trials

An international team of researchers has shown that the new vaccine strengthens the immune system of nearly 400 healthy adults

In addition, monkeys vaccinated six times exposed to the disease, only one-third were infected. South African Women

At present, researchers from institutions such as Harvard, MIT, and the National Institute of Health have begun testing 2 600 women in South Africa who are at risk of becoming infected. until 2021.

The clinical study called "Imbokodo", which in Zulu means "rock" to represent the strength of women and their importance in the community

The results are an important step, "said Professor Dan Barouch, of Boston's Harvard Medical School, and Beth Israel's Deaconess Medical Center, who led the study.

He also stated that this study demonstrates that this vaccine induces a strong immune response in humans and monkeys, providing protection to 67% of monkeys.

"These results need to be interpreted with caution, the difficulties of developing an HIV vaccine are unprecedented, and the ability to induce a specific immune response to HIV does not necessarily indicate that a vaccine will protect against HIV." people against HIV, "said the professor

. "We look forward to the results of phase 2-aba Imbokodo, who will determine whether the vaccine will protect people from HIV infection," he added.

London, the highest rate of HIV prevalence

According to Terence Higgins Trust, in the UK, there are about 89,400 people living with HIV and about 10,400 who do not do not know that they are infected

London continues to have the highest prevalence of HIV in the UK, with 40% of people diagnosed living in the capital. Nearly 1 in 50 people living in the Lambeth District have this virus

However, improved medication helps control the disease and, for people aged 15-59 diagnosed early, the mortality rate is equal to the population as a whole

Worldwide, the situation is very different, with an estimated 37 million people infected with HIV, of whom only 50% receive anti-AIDS drugs

For the In the latest clinical trial, researchers recruited 393 healthy adults aged 18 to 50 in East African clinics. South Africa, Thailand and the United States between February 2015 and October 2015.